Abstract
Off-label use of medicines is common. Because many off-label uses have not been carefully studied, it is important that postmarketing drug safety systems be able to identify, assess, and monitor adverse events that occur in the off-label setting. The full range of postmarketing surveillance and analysis tools can be utilized to study the adverse effects of medicines used off-label.
Original language | English (US) |
---|---|
Pages (from-to) | 787-795 |
Number of pages | 9 |
Journal | Clinical Pharmacology and Therapeutics |
Volume | 91 |
Issue number | 5 |
DOIs | |
State | Published - May 2012 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)